Clinical trial
The Effect of Rituximab on the Humoral Response to Influenza Vaccine
NCT00466037 · Tel-Aviv Sourasky Medical Center, Other · Terminated
Key facts
| NCT number | NCT00466037 |
|---|---|
| Title | The Effect of Rituximab on the Humoral Response to Influenza Vaccine |
| Official title | Vaccination Against Influenza in Rheumatoid Arthritis Patients: The Effect of Rituximab on the Humoral Response |
| Lead sponsor | Tel-Aviv Sourasky Medical Center, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological |
| Interventions | Influenza vaccine |
| Enrollment | 64 |
| Start date | Sep 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Apr 27, 2007 |
| Last update posted | Apr 27, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: